Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG, Schoppe WD, Fuchs R, Pflüger KH, Loeffler M, Diehl V. Pfreundschuh MG, et al. Among authors: pfluger kh. Cancer Treat Rep. 1987 Dec;71(12):1203-7. Cancer Treat Rep. 1987. PMID: 2446751
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin Study Group.
Hiddemann W, Schmitz N, Pfreundschuh M, Pflüger KH, Ollech-Chwoyka J, Tirier C, Maschmeyer G, Kirchner H, Wagner T, Koch P, et al. Hiddemann W, et al. Among authors: pfluger kh. Cancer. 1990 Sep 1;66(5):838-43. doi: 10.1002/1097-0142(19900901)66:5<838::aid-cncr2820660504>3.0.co;2-r. Cancer. 1990. PMID: 2386912
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Fuchs R, Löffler M, Pfreundschuh M, Dölken G, Gerhartz H, Hagen-Aukamp U, Hiller E, Petsch S, Pflüger KH, Rühl U, et al. Fuchs R, et al. Among authors: pfluger kh. Leuk Lymphoma. 1994 Jun;14(1-2):79-89. doi: 10.3109/10428199409049653. Leuk Lymphoma. 1994. PMID: 7522721 Clinical Trial.
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.
Eichhorst BF, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R, Hallek M; German CLL Study Group (GCLLSG). Eichhorst BF, et al. Blood. 2011 Feb 10;117(6):1817-21. doi: 10.1182/blood-2010-04-282228. Epub 2010 Dec 7. Blood. 2011. PMID: 21139079 Free article.
Multiple myeloma of the bladder and vagina.
Weide R, Pflüger KH, Görg C, Rohrmoser L, Neumann K, Havemann K. Weide R, et al. Among authors: pfluger kh. Cancer. 1990 Sep 1;66(5):989-91. doi: 10.1002/1097-0142(19900901)66:5<989::aid-cncr2820660531>3.0.co;2-m. Cancer. 1990. PMID: 2386927
Pharmacokinetics of high-dose etoposide after short-term infusion.
Köhl P, Köppler H, Schmidt L, Fritsch HW, Holz J, Pflüger KH, Jungclas H. Köhl P, et al. Among authors: pfluger kh. Cancer Chemother Pharmacol. 1992;29(4):316-20. doi: 10.1007/BF00685951. Cancer Chemother Pharmacol. 1992. PMID: 1537079
Multiple myeloma of the serosa coat.
Görg C, Adler G, Görg K, Pflüger KH, Havemann K. Görg C, et al. Among authors: pfluger kh. J Cancer Res Clin Oncol. 1988;114(3):312-6. doi: 10.1007/BF00405841. J Cancer Res Clin Oncol. 1988. PMID: 3384845
96 results